Loading provider…
Loading provider…
Hematology & Oncology Physician in Jacksonville, FL
NPI: 1386876928Primary Practice Location
MAYO CLINIC
4500 San Pablo Rd S, Jacksonville, FL
Primary Employer
Mayo Clinic Jacksonville
mayoclinic.org
HQ Phone
Get MD Pooja's Phone Numberphone_androidMobile
Get MD Pooja's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
FL State Medical License
2012 - 2026
GA State Medical License
2024 - 2025

American Board of Internal Medicine
Medical Oncology
University at Buffalo
Residency • Internal Medicine
2009 - 2012
Mayo Clinic Alix School of Medicine - Rochester
college.mayo.edu
Fellowship • Hematology and Medical Oncology
2012 - 2015
Dr. DY Patil Medical College
Medical School
Until 2007
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 173 | 279 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 47 | 47 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 24 | 30 |
| 4 | 99211Established patient office or other outpatient visit, typically 5 minutes | 11 | 13 |
| 5 | 99205New patient office or other outpatient visit, typically 60 minutes | 11 | 11 |
Authors: James Foran, Radhika Ghosh, Gerardo Colon-Otero, Sikander Ailawadhi, Abhisek Swaika, Vivek Roy, Asher Chanan-Khan
Journal: Cancer
Publication Date: 2015-11-13
Authors: Anthony Jaslowski, Timothy Hobday, Edith Perez, Alvaro Moreno-Aspitia, Jennifer Crozier
Journal: Clin Breast Cancer
Publication Date: 2015-08-19
Lead Sponsor: Sermonix Pharmaceuticals Inc.
Intervention / Treatment: DRUG: Fulvestrant in combination with abemaciclib, DRUG: Lasofoxifene in combination with abemaciclib
Lead Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Intervention / Treatment: DRUG: Placebo, DRUG: Trastuzumab, DRUG: Pertuzumab, DRUG: Tucatinib, DRUG: Combination product: Trastuzumab + Pertuzumab
Lead Sponsor: Mayo Clinic
Intervention / Treatment: OTHER: Questionnaire Administration, DEVICE: Medical Device Usage and Evaluation